小牛血清去蛋白联合奥扎格雷钠治疗急性脑梗死的疗效

acute cerebral infarction.Methods A total of 114 patients with acute cerebral infarction admitted to our hospital from January 2018 to January 2019
were enrolled. According to the random number table method, they were divided into control group and study group, with 57 cases in each group. The
统计学意义渊 约0.05冤曰研究组总有效率为 96.49%袁高于对照组的 84.21%袁差异有统计学意义渊 约0.05冤曰研究组不良反应发生率
为 7.02%袁高于对照组的 3.51%袁但差异无统计学意义渊 跃0.05冤遥 结论 小牛血清去蛋白联合奥扎格雷钠治疗急性脑梗死疗效确
切袁可显著改善患者的神经功能袁提高生活能力袁未明显增加不良反应遥
2.Department of Clinical Laboratory,Jiamusi City Hospital of Traditional Chinese Medicine, Jiamusi 154002,Heilongjiang,China)
Abstract：Objective To investigate the effects of calf serum deproteination combined with ozagrel sodium on neurological function in patients with
关键词院急性脑梗死曰小牛血清去蛋白曰奥扎格雷钠曰神经功能
中图分类号院R743.3
文献标识码院A
DOI:10.3969/j.issn.1006-1959.2019.16.048
文章编号院1006-1959渊2019冤16-0143-03
Efficacy of Calf Serum Deproteination Combined with Sodium Ozagrel in
control group was treated with sodium ozagrel. The study group was treated with calf serum deproteinized injection on the basis of the control group for
Results After treatment, the scores of neurological deficits and viability of the two groups were improved compared with those before treatment, and
the study group was superior to the control group,the difference was statistically significant ( <0.05). The total effective rate of the study group was
摘要院目的 探讨小牛血清去蛋白联合奥扎格雷钠对急性脑梗死患者神经功能的影响遥 方法 选取我院 2018 年 1 月~2019 年 1 月收治的 114 例急性脑梗塞患者为研究对象遥 按照随机数表法分为对照组和研究组袁每组 57 例遥 对照组采用奥扎格雷钠治疗袁 研究组在对照组基础上加用小牛血清去蛋白注射液治疗袁疗程 2 周遥比较两组治疗前后神经功能缺损程度尧生活能力评分袁治疗 后临床疗效及不良反应遥 结果 治疗后两组神经功能缺损程度及生活能力评分均较治疗前改善袁且研究组优于对照组袁差异有
0.05). Conclusion Calf serum deproteination combined with sodium ozagrel is effective in thenfarction, which can
the Treatment of Acute Cerebral Infarction
CHEN Xi1,KOU Tian2
(1.Department of Neurology,Subject One,Jiamusi Central Hospital,Jiamusi 154002,Heilongjiang,China;
96.49% , which was higher than that of the control group 84.21% ,the difference was statistically significant ( <0.05). The incidence of adverse
reactions in the study group was 7.02%, which was higher than that of the control group 3.51%, but the difference was not statistically significant ( >
2 weeks. The neurological deficits, life ability scores, clinical efficacy and adverse reactions after treatment were compared between the two groups.
医学信息 2019 年 8 月第 32 卷第 16 期
Medical Information Aug. 2019 Vol. 32 No.16
药物与临床
小牛血清去蛋白联合奥扎格雷钠治疗急性脑梗死的疗效
陈 曦 1袁寇 天 2
渊1.佳木斯市中心医院神经内一科, 黑龙江 佳木斯 154002曰
2.佳木斯市中医院检验科袁黑龙江 佳木斯 154002冤